الفهرس | Only 14 pages are availabe for public view |
Abstract H igh Flow Nasal Oxygen (HFNO2) therapy provides warmed humidified oxygen and low-level, flow-dependent positive airways pressure, and may be more tolerable than Continuous positive airway pressure (CPAP) or non-invasive ventilation; also, HFNO2 improves washout of nasopharyngeal dead space, resulting in improved oxygenation. In giving prophylactic support to preterm newborns after extubation, HFNO2 has been demonstrated to be both safe and non-inferior to standard CPAP with lower incidence of nasal trauma than in the CPAP group. When compared with standard care, prophylactic postoperative high-flow nasal oxygen reduced hospital length of stay and intensive care unit re-admission. Our study has shown that High Flow Nasal Oxygen Therapy in postoperative laparoscopic sleeve gastrectomy patients with atelectasis maintained oxygenation represented as PaO2 and PaO2/ FiO2 higher than the Venturi mask and significantly decreased the respiratory rate but did not decrease the length of ICU stay, did not decrease the time needed for Oxygen therapy when compared to Venturi Mask Oxygen Therapy. No Radiological improvement was noted using Lung U/S score and m-RAS score in both groups. CONCLUSION I n conclusion, our study has shown that High Flow Nasal Oxygen Therapy in postoperative laparoscopic sleeve gastrectomy patients with atelectasis maintained oxygenation represented as PaO2 and PaO2/ FiO2 higher than the Venturi mask and significantly decreased the respiratory rate but did not decrease the length of ICU stay, did not decrease the time needed for Oxygen therapy when compared to Venturi Mask Oxygen Therapy. No Radiological improvement was noted using Lung U/S score and m-RAS score in both groups. |